Abstract |
Cogan and Behcet syndromes are considered large vessel vasculitides. Both are rare diseases, with varied clinical manifestations affecting multiple organ systems. Although both have hallmark symptoms (ocular and vestibuloauditory inflammation in Cogan syndrome and aphthous ulcers in Behcet syndrome), neither has confirmatory diagnostic testing. Delayed diagnosis can result in poor outcomes. In both syndromes, large vessel arterial inflammation may result in severe morbidity and mortality. Treatment strategies in both syndromes vary based on organ system involvement and severity of manifestations. In this article, the epidemiology, proposed pathogenesis, manifestations, and the most current treatment paradigms for these syndromes are reviewed.
|
Authors | Ora Singer |
Journal | Rheumatic diseases clinics of North America
(Rheum Dis Clin North Am)
Vol. 41
Issue 1
Pg. 75-91, viii
( 2015)
ISSN: 1558-3163 [Electronic] United States |
PMID | 25399941
(Publication Type: Journal Article, Review)
|
Chemical References |
- Glucocorticoids
- Immunosuppressive Agents
|
Topics |
- Audiometry
- Behcet Syndrome
(diagnosis, drug therapy, immunology)
- Cogan Syndrome
(diagnosis, drug therapy, immunology)
- Glucocorticoids
(therapeutic use)
- Humans
- Immunosuppressive Agents
(therapeutic use)
- Ophthalmoscopy
- Severity of Illness Index
- Slit Lamp
|